Jonathan Baum, the chairman and CEO of Dreyfus , resigned from the firm on Monday, Jan. 21, to pursue other interests, Morningstar reports.
Plus, news on Fidelity, American Century, T. Rowe Price, and more.
Danaos' fleet-expansion plans should continue to support its hefty dividend.
There is far more variety now, but new doesn’t necessarily mean better.
These five funds are solid defensive plays.
Joyce is also set to leave GMO. Also, American Century's LIVESTRONG funds withstand Lance Armstrong controversy, Dreyfus' CEO departs, manager changes at Fidelity and American Century, and analyst reductions at UBS Global Asset Management.